0

ALRN 5281

ALRN 5281

$130.00

ALRN-5281 is being studied as a safer, more targeted way to activate your body’s natural healing and performance pathways. Whether you’re battling fatigue, muscle loss, slow recovery, or just looking to optimize your edge, ALRN-5281 could be the upgrade your body’s been waiting for.

Description

 

Unlock Your Peak Potential with ALRN-5281
Feel Younger. Train Smarter. Recover Faster.

Imagine a solution designed not just to fight aging—but to help your body restore, repair, and rebuild itself from the inside out. That’s the promise of ALRN-5281, a revolutionary investigational peptide that mimics growth hormone-releasing hormone (GHRH) to naturally boost your body’s growth hormone levels—without the harmful spikes associated with synthetic injections.

ALRN-5281 is being studied as a safer, more targeted way to activate your body’s natural healing and performance pathways. Whether you’re battling fatigue, muscle loss, slow recovery, or just looking to optimize your edge, ALRN-5281 could be the upgrade your body’s been waiting for.

Unlike standard growth hormone therapies, this peptide is being developed with precision and long-acting effects in mind. Early research shows promising outcomes for individuals seeking increased muscle mass, fat loss, improved sleep, and faster recovery.


Why Consider ALRN-5281?

Boost natural growth hormone without overstimulation
Support lean muscle growth and fat metabolism
Enhance sleep quality and recovery
Potential for anti-aging, skin tone improvement, and cognitive wellness


Backed by Science:

  1. Guerrant et al. (2016), Endocrinology
    In a preclinical study, ALRN-5281 demonstrated long-lasting growth hormone (GH) secretion and increased IGF-1 levels in primates without the side effects seen with continuous GH administration.
    Guerrant, W., et al. Endocrinology, 2016.
  2. Culler et al. (2011), The Journal of Pharmacology and Experimental Therapeutics
    ALRN-5281 was shown to be a potent and selective GHRH analog that increased lean body mass and decreased fat mass in animal models, suggesting a valuable application in age-related decline.
    Culler, M. D., et al., JPET, 2011.
  3. Allon Therapeutics/Aileron Therapeutics Phase 1 Clinical Trials (2018)
    In early-phase human studies, ALRN-5281 was found to be well-tolerated and effective in stimulating GH and IGF-1 levels with a single weekly dose, supporting its potential for once-weekly use in humans.

 

If you’re interested in learning more about ALRN-5281, you may request a private consultation with a licensed physician or proceed directly to browse available peptides in our Research Catalog.

Take control of your performance—starting at the cellular level.

Additional information

Size

1mg